Company news
Shield Therapeutics Plc (LSE:STX) news
Shield Therapeutics Plc news releases on 6ix. Latest, Jul 6, 2017: Feraccru licence agreement for Switzerland
Press releases — page 5
Feraccru licence agreement for Switzerland
July 6, 2017
Warrant Exercise and Expiry
July 3, 2017
Admission of New Ordinary Shares
June 28, 2017
Biomarker data on ferric maltol in patients
June 22, 2017
Results of Fundraise
June 15, 2017
Annual Report, Accounts and AGM Notification
April 28, 2017
Appointment of Chief Financial Officer
April 4, 2017
IP Portfolio Update
March 13, 2017
Directorate and Secretarial Update
January 30, 2017
Interim Results for six months ended 30 June 2016
September 20, 2016
Grant of Share Awards
September 13, 2016
Composition of Matter Patent Granted on Feraccru®
September 7, 2016
Presenting at Canaccord Genuity Conference, Boston
August 1, 2016
2015 Annual Report and Accounts and Notice of AGM
June 30, 2016
Maiden Preliminary Results for FY15
June 14, 2016
Notice of results and change of accounting date
March 23, 2016
First Day of Dealings on AIM
February 26, 2016